See related separate article Nosebleeds (Epistaxis).
Nasal cautery is a common treatment of small lesions and epistaxis. A caustic agent such as silver nitrate (chemical cautery), or an electrically charged wire such as platinum (electrocautery) is used to stop bleeding in the nasal mucous membrane. Chemical cautery of the visible blood vessels on the anterior part of the nasal septum is the most popular treatment method for idiopathic recurrent nosebleeds.1
Nasal cautery for epistaxis2If other methods such as direct pressure are unsuccessful, cautery is then performed to stop bleeding and prevent reoccurrence. Cautery of blood vessels visible anteriorly is much easier than those which bleed posteriorly. A device which combines suction, a cautery stick and a protective sheath has been devised for this use.3
|
On this page
Complications1
- Serious adverse effects are rare.
- Silver nitrate cautery may be painful.
- Cautery often proves ineffective (telangiectatic vessels may reappear at the edges of the cauterised area).
- Sclerosis of blood vessels may occur.
- Thickening of mucosa can be a complication.
- Itching is common, which can lead to increased nose picking, especially in children.
- Nose picking may delay healing, enable bacteria to colonise and cause further bleeding.
- Atrophy of nasal mucosa, septal crusting and perforation can occur.
- There may be a mucocutaneous reaction resulting in tattooing of the septal mucosa.
- Local anaesthetic may produce adverse effects.
Document references
- Burton MJ, Doree CJ; Interventions for recurrent idiopathic epistaxis (nosebleeds) in children. Cochrane Database Syst Rev. 2004;(1):CD004461. [abstract]
- Leong SC, Roe RJ, Karkanevatos A; No frills management of epistaxis. Emerg Med J. 2005 Jul;22(7):470-2. [abstract]
- Judd O; Novel method for safe cauterisation of posterior epistaxis. J Laryngol Otol. 2009 Aug;123(8):910-1. Epub 2009 Feb 16. [abstract]
Acknowledgements
EMIS is grateful to Dr Laurence Knott for writing this article and to Dr Huw Thomas for earlier versions. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2010.Document ID: 2490
Document Version: 21
Document Reference: bgp24553
Last Updated: 8 Apr 2010